In summary, results of these studies indicate that the inhibition of Rac1 using either pharmacological inhibitor or dominant negative mutant promotes apoptosis induction after IR in pancreatic cancer cells. This evidence concerns the gene RAC1 and familial pancreatic carcinoma.